- Report
- August 2025
- 181 Pages
Global
From €3140EUR$3,545USD£2,717GBP
€3489EUR$3,939USD£3,019GBP
- Report
- November 2024
- 150 Pages
Global
From €5270EUR$5,950USD£4,560GBP
- Report
- April 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- March 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- August 2025
- 266 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2657EUR$3,000USD£2,299GBP
- Report
- June 2025
- 250 Pages
United States
From €2470EUR$2,789USD£2,137GBP
- Report
- July 2025
- 150 Pages
Global
From €5270EUR$5,950USD£4,560GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Report
- June 2025
- 400 Pages
Global
From €4384EUR$4,949USD£3,793GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,137GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,137GBP
- Report
- March 2025
- 130 Pages
Global
From €3652EUR$4,123USD£3,159GBP
€4296EUR$4,850USD£3,717GBP
- Report
- July 2025
- 150 Pages
United States
From €5270EUR$5,950USD£4,560GBP
- Report
- August 2025
- 183 Pages
Global
From €3140EUR$3,545USD£2,717GBP
€3489EUR$3,939USD£3,019GBP
- Report
- August 2025
- 180 Pages
Global
From €3140EUR$3,545USD£2,717GBP
€3489EUR$3,939USD£3,019GBP
- Report
- August 2025
- 183 Pages
Global
From €3140EUR$3,545USD£2,717GBP
€3489EUR$3,939USD£3,019GBP
- Report
- January 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- March 2025
- 150 Pages
Global
From €3410EUR$3,850USD£2,951GBP
€4296EUR$4,850USD£3,717GBP

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs).
The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more